Unigene Laboratories, Inc. (UGNE) Company Profile


	The Wright Reports site is no longer hosted or operated by Manta. Please review the following: 1. You have been redirected to CorporateInformation.com where you can view Snapshot reports or purchase Wright reports or subscriptions of your choosing. 2. If you were previously linking to Wright Reports please change your links to www.corporateinformation.com 3. If you are a paid subscriber with an active subscription please continue on to the member site: http://member.corporateinformation.com/home.asp 4. For additional information related to CorporateInformation.com please contact help@corporateinformation.com, Contact phone nr to be provided later)

Unigene Laboratories, Inc. Company Snapshot

Business Description:

Unigene Laboratories, Inc. operates in the Medicinals and botanicals sector. Unigene Laboratories, Inc. is a biopharmaceutical company. The Company focuses on the research, production and delivery of small proteins, referred to as peptides, for medical use. The Company has three operating locations: administrative and regulatory offices in Boonton, New Jersey; a laboratory research facility in Fairfield, New Jersey, and a pharmaceutical production facility in Boonton, New Jersey. Its primary focus has been on the development of calcitonin and other peptide products for the treatment of osteoporosis and other indications. In our complete report available for purchase the company is compared to: Huifeng Bio-Pharmaceutical Technology, Inc., Cyanotech Corporation and Bond Laboratories, Incorporation.

Unigene Laboratories, Inc.

Stock Data:

Recent Stock Performance:

Current Price (2/3/2012): .62
(Figures in U.S. Dollars)

1 Week	-0.8%	13 Weeks	13.8%

4 Weeks	-36.7%	52 Weeks	-22.6%

Unigene Laboratories, Inc. Key Data:

Ticker:	UGNE	Country:	UNITED STATES

Exchanges:	OTC	Major Industry:	Drugs, Cosmetics & Health Care

		Sub Industry:	Ethical Drug Manufacturers

2010 Sales	11,340,214 (Year Ending Jan 2011).	Employees:	68

Currency:	U.S. Dollars	Market Cap:	58,723,671

Fiscal Yr Ends:	December	Shares Outstanding:	94,715,599

Share Type:	Common	Closely Held Shares:	15,301,361

Feedback | Terms and Conditions | Privacy Policy | Site Index

CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.